Risk of Neurological Adverse Events during Tumour Necrosis Factor Inhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry

被引：0
|
作者：
Dreyer, Lene [1 ,2 ,3 ]
Kopp, Tine Iskov [4 ]
Jacobsen, Rikke Kart [5 ]
Magyari, Melinda [4 ]
Ibfelt, Else Helene [5 ]
Locht, Henning [6 ]
Sellebjerg, Finn Thorup [4 ]
Jensen, Dorte Vendelbo [7 ,8 ]
Cordtz, Rene [9 ]
机构：
[1] Aalborg Univ Hosp, Dept Rheumatol, DK-9000 Aalborg, Denmark
[2] Aalborg Univ Hosp, Dept Clin Med, DK-9000 Aalborg, Denmark
[3] Aalborg Univ, DK-9000 Aalborg, Denmark
[4] Copenhagen Univ Hosp, Dept Neurol, Rigshosp, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark
[5] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark
[6] Frederiksberg Univ Hosp, Dept Rheumatol, Copenhagen, Denmark
[7] DANBIO Registry, Copenhagen, Denmark
[8] Danish Dept Rheumatol, Copenhagen, Denmark
[9] Gentofte Rigshosp, Ctr Rheumatol & Spine Dis, Hellerup, Denmark
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2955
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry
    Kopp, Tine I.
    Jacobsen, Rikke K.
    Magyari, Melinda
    Ibfelt, Else H.
    Locht, Henning
    Sellebjerg, Finn T.
    Vendelbo, Dorte
    Cordtz, Rene
    Dreyer, Lene
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 145 - 145
  • [2] RISK OF NEUROLOGICAL ADVERSE EVENTS DURING TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT FOR ARTHRITIS: A POPULATION-BASED COHORT STUDY FROM DANBIO AND ARTIS
    Kopp, Tine Iskov
    Arkema, Elizabeth
    Cordtz, Rene
    Delcoigne, Benedicte
    Askling, Johan
    Dreyer, Lene
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 211 - 211
  • [3] Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry
    Dreyer, L.
    Magyari, M.
    Laursen, B.
    Cordtz, R.
    Sellebjerg, F.
    Locht, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (04) : 785 - 786
  • [4] Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)
    Dreyer, L.
    Magyari, M.
    Laursen, B.
    Cordtz, R.
    Sellebjerg, F.
    Locht, H.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 27 - 28
  • [5] MULTIPLE SCLEROSIS DURING TUMOR NECROSIS FACTOR INHIBITOR TREATMENT FOR ARTHRITIS - A POPULATION BASED STUDY FROM DANBIO AND THE DANISH MULTIPLE SCLEROSIS REGISTRY
    Dreyer, L.
    Magyari, M.
    Laursen, B.
    Cordtz, R.
    Sellebjerg, F.
    Locht, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 708 - 708
  • [6] Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry
    Ornbjerg, Lykke Midtboll
    Ostergaard, Mikkel
    Boyesen, Pernille
    Krogh, Niels Steen
    Thormann, Anja
    Tarp, Ulrik
    Poulsen, Uta Engling
    Espesen, Jakob
    Ringsdal, Vibeke Stevenius
    Graudal, Niels
    Kollerup, Gina
    Jensen, Dorte Vendelbo
    Madsen, Ole Rintek
    Glintborg, Bente
    Christensen, Torben
    Lindegaard, Hanne
    Dencker, Ditte
    Hansen, Annette
    Andersen, Anne Rodgaard
    Hetland, Merete Lund
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (01) : 57 - 63
  • [7] GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY
    Lauridsen, K. B.
    Duch, K.
    Mortensen, A. S.
    Cordtz, R.
    Kristensen, S.
    Hetland, M. L.
    Dreyer, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 310 - 311
  • [8] Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registry
    Hojgaard, Pil
    Glintborg, Bente
    Hetland, Merete Lund
    Hansen, Torben Hojland
    Lage-Hansen, Philip Rask
    Petersen, Martin H.
    Holland-Fischer, Mette
    Nilsson, Christine
    Loft, Anne Gitte
    Andersen, Bjarne Nesgaard
    Adelsten, Thomas
    Jensen, Jorgen
    Omerovic, Emina
    Christensen, Regitse
    Tarp, Ulrik
    Ostgard, Rene
    Dreyer, Lene
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2130 - 2136
  • [9] PRESCRIPTION PATTERNS OF TUMOUR NECROSIS FACTOR INHIBITOR AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A NORDIC POPULATION-BASED COHORT STUDY
    Jorgensen, T. S.
    Dreyer, L.
    Gudbjornsson, B.
    Hetland, M. L.
    Glintborg, B.
    Askling, J.
    Chatzidionysiou, K.
    Di Giuseppe, D.
    Jacobsson, L.
    Wallman, J. K.
    Kristianslund, E. K.
    Olsen, I. C.
    Fagerli, K.
    Lie, E.
    Nordstrom, D.
    Aaltonen, K.
    Joensuu, J.
    Love, T. J.
    Geirsson, A. J.
    Kristensen, L. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 686 - 686
  • [10] Impact of tumour necrosis factor inhibitor treatment on hand bone loss in rheumatoid arthritis patients treated in clinical practice: results from the nationwide Danish DANBIO registry
    Ornbjerg, L. M.
    Ostergaard, M.
    Boyesen, P.
    Jensen, T.
    Thormann, A.
    Tarp, U.
    Bohme, W.
    Dencker, D.
    Lindegaard, H.
    Poulsen, U. E.
    Hansen, A.
    Ringsdal, V.
    Schlemmer, A.
    Graudal, N.
    Andersen, A. R.
    Espesen, J.
    Kollerup, G.
    Christensen, T.
    Pelck, R.
    Glintborg, B.
    Madsen, O.
    Jensen, D. V.
    Majgaard, O.
    Hetland, M.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 27 - 28
12345